We are live on
!
Find out more
HA
HHLR Advisors Portfolio holdings
AUM
$1.67B
1-Year Est. Return
7.53%
This Fund
S&P 500
This Quarter
Est. Return
-15.01%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
–
AUM
$2.41B
AUM Growth
–
Cap. Flow
+$2.47B
Cap. Flow
% of AUM
102.3%
Top 10 Holdings %
Top 10 Hldgs %
82.56%
Holding
32
New
32
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONC
BeOne Medicines Ltd
ONC
|
+$589M |
| 2 |
JD.com
JD
|
+$337M |
| 3 |
Alibaba
BABA
|
+$209M |
| 4 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
+$202M |
| 5 |
TAL Education Group
TAL
|
+$198M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.24% |
| 2 | Consumer Discretionary | 22.72% |
| 3 | Consumer Staples | 15.66% |
| 4 | Communication Services | 7.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONC
1
BeOne Medicines Ltd
ONC
$34B
| $622M | 25.82% |
+4,437,953
| New | +$589M |
|
|
2
JD.com
JD
$43.2B
| $315M | 13.06% |
+15,041,243
| New | +$337M |
|
|
CBPO
3
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $209M | 8.66% |
+2,751,200
| New | +$202M |
|
|
4
TAL Education Group
TAL
$6B
| $199M | 8.27% |
+7,475,723
| New | +$198M |
|
|
5
Alibaba
BABA
$275B
| $194M | 8.03% |
+1,411,830
| New | +$209M |
|
6
Mondelez International
MDLZ
$84.1B
| $141M | 5.86% |
+3,529,264
| New | +$150M |
|
|
KYNB
7
Kyntra Bio
KYNB
$28.2M
| $92.7M | 3.85% |
+80,131
| New | +$90.1M |
|
|
WUBA
8
DELISTED
58.com Inc
WUBA
| $80.5M | 3.34% |
+1,484,641
| New | +$90.5M |
|
|
BPMC
9
DELISTED
Blueprint Medicines
BPMC
| $77.1M | 3.2% |
+1,430,949
| New | +$87M |
|
|
KANG
10
DELISTED
iKang Healthcare Group, Inc.
KANG
| $59.6M | 2.47% |
+2,922,834
| New | +$52M |
|
|
MYOK
11
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $41.9M | 1.74% |
+858,340
| New | +$47.2M |
|
|
LN
12
DELISTED
LINE Corporation
LN
| $41.2M | 1.71% |
+1,207,763
| New | +$39.9M |
|
13
Kiniksa Pharmaceuticals
KNSA
$6.13B
| $39M | 1.62% |
+1,388,888
| New | +$29M |
|
14
Pinduoduo
PDD
$125B
| $38.8M | 1.61% |
+1,730,096
| New | +$36.5M |
|
15
Snap
SNAP
$8.07B
| $38.2M | 1.58% |
+6,925,129
| New | +$45M |
|
|
BEDU
16
DELISTED
Bright Scholar Education Holdings
BEDU
| $36.7M | 1.52% |
+996,449
| New | +$43.2M |
|
17
Bilibili
BILI
$7.81B
| $31.8M | 1.32% |
+2,177,931
| New | +$30.5M |
|
|
APLS
18
DELISTED
Apellis Pharmaceuticals
APLS
| $29.4M | 1.22% |
+2,229,708
| New | +$34.2M |
|
19
Tencent Music
TME
$16.1B
| $19.4M | 0.81% |
+1,470,491
| New | +$18.8M |
|
|
LOXO
20
DELISTED
Loxo Oncology, Inc
LOXO
| $18.4M | 0.76% |
+131,300
| New | +$19.9M |
|
|
GTHX
21
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $18.2M | 0.75% |
+949,431
| New | +$35.6M |
|
22
iQIYI
IQ
$1.19B
| $16.8M | 0.7% |
+1,132,816
| New | +$23.6M |
|
|
SOHU
23
Sohu.com
SOHU
$348M
| $14M | 0.58% |
+802,034
| New | +$15.3M |
|
|
JOYY
24
JOYY Inc
JOYY
$3.74B
| $11.6M | 0.48% |
+193,490
| New | +$12.6M |
|
25
Arvinas
ARVN
$530M
| $8.03M | 0.33% |
+625,000
| New | +$9.91M |
|
Similar funds
TFS
GC
PA
LCI
JPM
NRI
CPO
JIP
HHLR Advisors's Q4 2018 Portfolio in Review
Q4 2018 is the first quarter with a 13F filing on record for HHLR Advisors, which disclosed 32 positions worth $2.41B. Its ten largest holdings account for 83% of the portfolio.
Its largest position is BeOne Medicines Ltd: 4,437,953 shares worth $622M.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, followed by Consumer Discretionary and Consumer Staples.
- HHLR Advisors's largest Q4 2018 buy was BeOne Medicines Ltd: 4,437,953 shares worth $622M.
- HHLR Advisors's ten largest holdings make up 83% of its $2.41B portfolio in Q4 2018.
- HHLR Advisors disclosed 32 positions in Q4 2018, its first 13F filing on record.
Based on HHLR Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.